Translational control of the HIV unspliced genomic RNA

Viruses

Volumn 7, Issue 8, 2015, Pages 4326-4351

  Rojas Araya, Bárbara ^a   Ohlmann, Théophile ^b,c,d,e   Soto Rifo, Ricardo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE LYON   (France)

^e CNRS   (France)

Author keywords

Cap dependent translation; DDX3; HIV 1; IRES; Nuclear export; Rev

Indexed keywords

GENOMIC RNA; RIBONUCLEOPROTEIN; VIRUS PROTEIN; VIRAL PROTEIN; VIRUS RNA;

GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; RNA SPLICING; RNA TRANSLATION; SEQUENCE ANALYSIS; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION;

CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HIV-2; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BIOSYNTHESIS; RIBONUCLEOPROTEINS; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84941030890     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7082822     Document Type: Review

References (178)

1. Killian, M.S.; Levy, J.A. HIV/AIDS: 30 Years of progress and future challenges. Eur. J. Immunol. 2011, 41, 3401-3411. [CrossRef] [PubMed]
2. Matreyek, K.A.; Engelman, A. Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes. Viruses 2013, 5, 2483-2511. [CrossRef] [PubMed]
3. Arya, S.K. Human and simian immunodeficiency retroviruses: Activation and differential transactivation of gene expression. AIDS Res. Hum. Retrovir. 1988, 4, 175-186. [CrossRef] [PubMed]
4. Berkhout, B.; Jeang, K.T. Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 1989, 63, 5501-5504. [PubMed]
5. Cullen, B.R. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986, 46, 973-982. [CrossRef]
6. Gatignol, A. Transcription of HIV: Tat and cellular chromatin. Adv. Pharmacol. 2007, 55, 137-159. [PubMed]
7. Jones, K.A. HIV trans-activation and transcription control mechanisms. New Biol. 1989, 1, 127-135. [PubMed]
8. Tazi, J.; Bakkour, N.; Marchand, V.; Ayadi, L.; Aboufirassi, A.; Branlant, C. Alternative splicing: Regulation of HIV-1 multiplication as a target for therapeutic action. FEBS J. 2010, 277, 867-876. [CrossRef] [PubMed]
9. Purcell, D.F.; Martin, M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 1993, 67, 6365-6378. [PubMed]
10. Schwartz, S.; Felber, B.K.; Benko, D.M.; Fenyo, E.M.; Pavlakis, G.N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 1990, 64, 2519-2529. [PubMed]
11. Schwartz, S.; Felber, B.K.; Pavlakis, G.N. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 1991, 183, 677-686. [CrossRef]
12. Guerrero, S.; Batisse, J.; Libre, C.; Bernacchi, S.; Marquet, R.; Paillart, J.C. HIV-1 replication and the cellular eukaryotic translation apparatus. Viruses 2015, 7, 199-218. [CrossRef] [PubMed]
13. Bogerd, H.P.; Echarri, A.; Ross, T.M.; Cullen, B.R. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J. Virol. 1998, 72, 8627-8635. [PubMed]
14. Dillon, P.J.; Nelbock, P.; Perkins, A.; Rosen, C.A. Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. J. Virol. 1990, 64, 4428-4437. [PubMed]
15. Emerman, M.; Vazeux, R.; Peden, K. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 1989, 57, 1155-1165. [CrossRef]
16. Fischer, U.; Huber, J.; Boelens, W.C.; Mattaj, I.W.; Luhrmann, R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82, 475-483. [CrossRef]
17. Le, S.Y.; Malim, M.H.; Cullen, B.R.; Maizel, J.V. A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res. 1990, 18, 1613-1623. [CrossRef] [PubMed]
18. Lewis, N.; Williams, J.; Rekosh, D.; Hammarskjold, M.L. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J. Virol. 1990, 64, 1690-1697. [PubMed]
19. Malim, M.H.; Hauber, J.; Le, S.Y.; Maizel, J.V.; Cullen, B.R. The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338, 254-257. [CrossRef] [PubMed]
20. Neville, M.; Stutz, F.; Lee, L.; Davis, L.I.; Rosbash, M. The importin-β family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 1997, 7, 767-775. [CrossRef]
21. Chiu, Y.L.; Coronel, E.; Ho, C.K.; Shuman, S.; Rana, T.M. HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA. J. Biol. Chem. 2001, 276, 12959-12966. [CrossRef] [PubMed]
22. Chiu, Y.L.; Ho, C.K.; Saha, N.; Schwer, B.; Shuman, S.; Rana, T.M. Tat stimulates cotranscriptional capping of HIV mRNA. Mol. Cell 2002, 10, 585-597. [CrossRef]
23. Shatkin, A.J. Capping of eucaryotic mRNAs. Cell 1976, 9, 645-653. [CrossRef]
24. Karn, J.; Stoltzfus, C.M. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb. Perspect. Med. 2012, 2. [CrossRef] [PubMed]
25. Chang, D.D.; Sharp, P.A. Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989, 59, 789-795. [CrossRef]
26. Lu, X.B.; Heimer, J.; Rekosh, D.; Hammarskjold, M.L. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. USA 1990, 87, 7598-7602. [CrossRef] [PubMed]
27. Stutz, F.; Rosbash, M. A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO J. 1994, 13, 4096-4104. [PubMed]
28. Han, J.; Xiong, J.; Wang, D.; Fu, X.D. Pre-mRNA splicing: Where and when in the nucleus. Trends Cell Biol. 2011, 21, 336-343. [CrossRef] [PubMed]
29. Cullen, B.R. Nuclear mRNA export: Insights from virology. Trends Biochem. Sci. 2003, 28, 419-424. [CrossRef]
30. Cullen, B.R. Nuclear RNA export. J. Cell Sci. 2003, 116, 587-597. [CrossRef] [PubMed]
31. Gruter, P.; Tabernero, C.; von Kobbe, C.; Schmitt, C.; Saavedra, C.; Bachi, A.; Wilm, M.; Felber, B.K.; Izaurralde, E. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1998, 1, 649-659. [CrossRef]
32. Legrain, P.; Rosbash, M. Some cis-and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 1989, 57, 573-583. [CrossRef]
33. Nakielny, S.; Dreyfuss, G. Nuclear export of proteins and RNAs. Curr. Opin. Cell Biol. 1997, 9, 420-429. [CrossRef]
34. Stutz, F.; Izaurralde, E. The interplay of nuclear mRNP assembly, mRNA surveillance and export. Trends Cell Biol. 2003, 13, 319-327. [CrossRef]
35. Coyle, J.H.; Bor, Y.C.; Rekosh, D.; Hammarskjold, M.L. The Tpr protein regulates export of mRNAs with retained introns that traffic through the Nxf1 pathway. RNA 2011, 17, 1344-1356. [CrossRef] [PubMed]
36. Rajanala, K.; Nandicoori, V.K. Localization of nucleoporin Tpr to the nuclear pore complex is essential for Tpr mediated regulation of the export of unspliced RNA. PLoS ONE 2012, 7, e29921. [CrossRef] [PubMed]
37. Porrua, O.; Libri, D. RNA quality control in the nucleus: The Angels' share of RNA. Biochim. Biophys. Acta 2013, 1829, 604-611. [CrossRef] [PubMed]
38. Felber, B.K.; Hadzopoulou-Cladaras, M.; Cladaras, C.; Copeland, T.; Pavlakis, G.N. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 1989, 86, 1495-1499. [CrossRef] [PubMed]
39. Pollard, V.W.; Malim, M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52, 491-532. [CrossRef] [PubMed]
40. Groom, H.C.; Anderson, E.C.; Lever, A.M. Rev: Beyond nuclear export. J. Gen. Virol. 2009, 90, 1303-1318. [CrossRef] [PubMed]
41. Blissenbach, M.; Grewe, B.; Hoffmann, B.; Brandt, S.; Uberla, K. Nuclear RNA export and packaging functions of HIV-1 Rev revisited. J. Virol. 2010, 84, 6598-6604. [CrossRef] [PubMed]
42. Berger, J.; Aepinus, C.; Dobrovnik, M.; Fleckenstein, B.; Hauber, J.; Bohnlein, E. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology 1991, 183, 630-635. [CrossRef]
43. Bohnlein, E.; Berger, J.; Hauber, J. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: New insights into the domain structure of Rev and Rex. J. Virol. 1991, 65, 7051-7055. [PubMed]
44. Daly, T.J.; Cook, K.S.; Gray, G.S.; Maione, T.E.; Rusche, J.R. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 1989, 342, 816-819. [CrossRef] [PubMed]
45. Hope, T.J.; McDonald, D.; Huang, X.J.; Low, J.; Parslow, T.G. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: Essential residues near the amino terminus. J. Virol. 1990, 64, 5360-5366. [PubMed]
46. revprotein. Biochem. Biophys. Res. Commun. 1989, 162, 963-970. [CrossRef]
47. Malim, M.H.; Bohnlein, S.; Hauber, J.; Cullen, B.R. Functional dissection of the HIV-1 Rev trans-activator-Derivation of a trans-dominant repressor of Rev function. Cell 1989, 58, 205-214. [CrossRef]
48. Perkins, A.; Cochrane, A.W.; Ruben, S.M.; Rosen, C.A. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune Defic. Syndr. 1989, 2, 256-263. [PubMed]
49. Daugherty, M.D.; Booth, D.S.; Jayaraman, B.; Cheng, Y.; Frankel, A.D. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Natl. Acad. Sci. USA 2010, 107, 12481-12486. [CrossRef] [PubMed]
50. DiMattia, M.A.; Watts, N.R.; Stahl, S.J.; Rader, C.; Wingfield, P.T.; Stuart, D.I.; Steven, A.C.; Grimes, J.M. Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element. Proc. Natl. Acad. Sci. USA 2010, 107, 5810-5814. [CrossRef] [PubMed]
51. Cochrane, A.W.; Chen, C.H.; Rosen, C.A. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 1990, 87, 1198-1202. [CrossRef] [PubMed]
52. Malim, M.H.; McCarn, D.F.; Tiley, L.S.; Cullen, B.R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 1991, 65, 4248-4254. [PubMed]
53. Venkatesh, L.K.; Chinnadurai, G. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology 1990, 178, 327-330. [CrossRef]
54. Weichselbraun, I.; Farrington, G.K.; Rusche, J.R.; Bohnlein, E.; Hauber, J. Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. J. Virol. 1992, 66, 2583-2587. [PubMed]
55. Fornerod, M.; Ohno, M.; Yoshida, M.; Mattaj, I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90, 1051-1060. [CrossRef]
56. Daugherty, M.D.; Liu, B.; Frankel, A.D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 2010, 17, 1337-1342. [CrossRef] [PubMed]
57. Booth, D.S.; Cheng, Y.; Frankel, A.D. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA. eLife 2014, 3. [CrossRef] [PubMed]
58. Taniguchi, I.; Mabuchi, N.; Ohno, M. HIV-1 Rev protein specifies the viral RNA export pathway by suppressing TAP/NXF1 recruitment. Nucleic Acids Res. 2014, 42, 6645-6658. [CrossRef] [PubMed]
59. Suhasini, M.; Reddy, T.R. Cellular proteins and HIV-1 Rev function. Curr. HIV Res. 2009, 7, 91-100. [CrossRef] [PubMed]
60. Bohne, J.; Wodrich, H.; Krausslich, H.G. Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5ʹ end. Nucleic Acids Res. 2005, 33, 825-837. [CrossRef] [PubMed]
61. Ajamian, L.; Abrahamyan, L.; Milev, M.; Ivanov, P.V.; Kulozik, A.E.; Gehring, N.H.; Mouland, A.J. Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 2008, 14, 914-927. [CrossRef] [PubMed]
62. Jackson, R.J.; Hellen, C.U.; Pestova, T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 2010, 11, 113-127. [CrossRef] [PubMed]
63. Balvay, L.; Soto Rifo, R.; Ricci, E.P.; Decimo, D.; Ohlmann, T. Structural and functional diversity of viral IRESes. Biochim. Biophys. Acta 2009, 1789, 542-557. [CrossRef] [PubMed]
64. De Breyne, S.; Soto-Rifo, R.; Lopez-Lastra, M.; Ohlmann, T. Translation initiation is driven by different mechanisms on the HIV-1 and HIV-2 genomic RNAs. Virus Res. 2013, 171, 366-381. [CrossRef] [PubMed]
65. Grifo, J.A.; Tahara, S.M.; Morgan, M.A.; Shatkin, A.J.; Merrick, W.C. New initiation factor activity required for globin mRNA translation. J. Biol. Chem. 1983, 258, 5804-5810. [PubMed]
66. Prevot, D.; Darlix, J.L.; Ohlmann, T. Conducting the initiation of protein synthesis: The role of eIF4G. Biol. Cell 2003, 95, 141-156. [CrossRef]
67. Pause, A.; Methot, N.; Svitkin, Y.; Merrick, W.C.; Sonenberg, N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 1994, 13, 1205-1215. [PubMed]
68. Pause, A.; Sonenberg, N. Mutational analysis of a DEAD box RNA helicase: The mammalian translation initiation factor eIF-4A. EMBO J. 1992, 11, 2643-2654. [PubMed]
69. Rogers, G.W., Jr.; Richter, N.J.; Lima, W.F.; Merrick, W.C. Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J. Biol. Chem. 2001, 276, 30914-30922. [CrossRef] [PubMed]
70. Prevot, D.; Decimo, D.; Herbreteau, C.H.; Roux, F.; Garin, J.; Darlix, J.L.; Ohlmann, T. Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning. EMBO J. 2003, 22, 1909-1921. [CrossRef] [PubMed]
71. Korneeva, N.L.; Lamphear, B.J.; Hennigan, F.L.; Merrick, W.C.; Rhoads, R.E. Characterization of the two eIF4A-binding sites on human eIF4G-1. J. Biol. Chem. 2001, 276, 2872-2879. [CrossRef] [PubMed]
72. Lamphear, B.J.; Kirchweger, R.; Skern, T.; Rhoads, R.E. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 1995, 270, 21975-21983. [CrossRef] [PubMed]
73. Mader, S.; Lee, H.; Pause, A.; Sonenberg, N. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 1995, 15, 4990-4997. [PubMed]
74. Imataka, H.; Sonenberg, N. Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A. Mol. Cell. Biol. 1997, 17, 6940-6947. [PubMed]
75. Korneeva, N.L.; Lamphear, B.J.; Hennigan, F.L.; Rhoads, R.E. Mutually cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eIF4G-1. J. Biol. Chem. 2000, 275, 41369-41376. [CrossRef] [PubMed]
76. Ohlmann, T.; Rau, M.; Pain, V.M.; Morley, S.J. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E. EMBO J. 1996, 15, 1371-1382. [PubMed]
77. Rau, M.; Ohlmann, T.; Morley, S.J.; Pain, V.M. A reevaluation of the cap-binding protein, eIF4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate. J. Biol. Chem. 1996, 271, 8983-8990. [CrossRef] [PubMed]
78. Safer, B.; Kemper, W.; Jagus, R. Identification of a 48S preinitiation complex in reticulocyte lysate. J. Biol. Chem. 1978, 253, 3384-3386. [PubMed]
79. Kozak, M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc. Natl. Acad. Sci. USA 1995, 92, 2662-2666. [CrossRef] [PubMed]
80. Kozak, M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J. 1997, 16, 2482-2492. [CrossRef] [PubMed]
81. Wegrzyn, J.L.; Drudge, T.M.; Valafar, F.; Hook, V. Bioinformatic analyses of mammalian 5ʹ-UTR sequence properties of mRNAs predicts alternative translation initiation sites. BMC Bioinform. 2008, 9. [CrossRef] [PubMed]
82. Jackson, R.J. The ATP requirement for initiation of eukaryotic translation varies according to the mRNA species. Eur. J. Biochem. 1991, 200, 285-294. [CrossRef] [PubMed]
83. Pestova, T.V.; Kolupaeva, V.G. The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection. Genes Dev. 2002, 16, 2906-2922. [CrossRef] [PubMed]
84. Poyry, T.A.; Kaminski, A.; Jackson, R.J. What determines whether mammalian ribosomes resume scanning after translation of a short upstream open reading frame? Genes Dev. 2004, 18, 62-75. [CrossRef] [PubMed]
85. Parsyan, A.; Svitkin, Y.; Shahbazian, D.; Gkogkas, C.; Lasko, P.; Merrick, W.C.; Sonenberg, N. mRNA helicases: The tacticians of translational control. Nat. Rev. Mol. Cell Biol. 2011, 12, 235-245. [CrossRef] [PubMed]
86. Parsyan, A.; Shahbazian, D.; Martineau, Y.; Petroulakis, E.; Alain, T.; Larsson, O.; Mathonnet, G.; Tettweiler, G.; Hellen, C.U.; Pestova, T.V.; et al. The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 22217-22222. [CrossRef] [PubMed]
87. Pisareva, V.P.; Pisarev, A.V.; Komar, A.A.; Hellen, C.U.; Pestova, T.V. Translation initiation on mammalian mRNAs with structured 5ʹ UTRs requires DExH-box protein DHX29. Cell 2008, 135, 1237-1250. [CrossRef] [PubMed]
88. Hartman, T.R.; Qian, S.; Bolinger, C.; Fernandez, S.; Schoenberg, D.R.; Boris-Lawrie, K. RNA helicase A is necessary for translation of selected messenger RNAs. Nat. Struct. Mol. Biol. 2006, 13, 509-516. [CrossRef] [PubMed]
89. Jang, S.K.; Krausslich, H.G.; Nicklin, M.J.; Duke, G.M.; Palmenberg, A.C.; Wimmer, E. A segment of the 5ʹ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 1988, 62, 2636-2643. [PubMed]
90. Pelletier, J.; Sonenberg, N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334, 320-325. [CrossRef] [PubMed]
91. Jackson, R.J. The current status of vertebrate cellular mRNA IRESs. Cold Spring Harb. Perspect. Biol. 2013, 5. [CrossRef] [PubMed]
92. Yamasaki, S.; Anderson, P. Reprogramming mRNA translation during stress. Curr. Opin. Cell Biol. 2008, 20, 222-226. [CrossRef] [PubMed]
93. Johannes, G.; Carter, M.S.; Eisen, M.B.; Brown, P.O.; Sarnow, P. Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl. Acad. Sci. USA 1999, 96, 13118-13123. [CrossRef] [PubMed]
94. Holcik, M.; Sonenberg, N.; Korneluk, R.G. Internal ribosome initiation of translation and the control of cell death. Trends Genet. 2000, 16, 469-473. [CrossRef]
95. Pyronnet, S.; Dostie, J.; Sonenberg, N. Suppression of cap-dependent translation in mitosis. Genes Dev. 2001, 15, 2083-2093. [CrossRef] [PubMed]
96. Pyronnet, S.; Pradayrol, L.; Sonenberg, N. A cell cycle-dependent internal ribosome entry site. Mol. Cell 2000, 5, 607-616. [CrossRef]
97. Spriggs, K.A.; Stoneley, M.; Bushell, M.; Willis, A.E. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell 2008, 100, 27-38. [CrossRef] [PubMed]
98. Stoneley, M.; Willis, A.E. Cellular internal ribosome entry segments: Structures, trans-acting factors and regulation of gene expression. Oncogene 2004, 23, 3200-3207. [CrossRef] [PubMed]
99. Baudin, F.; Marquet, R.; Isel, C.; Darlix, J.L.; Ehresmann, B.; Ehresmann, C. Functional sites in the 5ʹ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 1993, 229, 382-397. [CrossRef] [PubMed]
100. Berkhout, B. Structure and function of the human immunodeficiency virus leader RNA. Prog. Nucleic Acid Res. Mol. Biol. 1996, 54, 1-34. [PubMed]
101. Paillart, J.C.; Dettenhofer, M.; Yu, X.F.; Ehresmann, C.; Ehresmann, B.; Marquet, R. First snapshots of the HIV-1 RNA structure in infected cells and in virions. J. Biol. Chem. 2004, 279, 48397-48403. [CrossRef] [PubMed]
102. Rosen, C.A.; Sodroski, J.G.; Haseltine, W.A. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985, 41, 813-823. [CrossRef]
103. Watts, J.M.; Dang, K.K.; Gorelick, R.J.; Leonard, C.W.; Bess, J.W., Jr.; Swanstrom, R.; Burch, C.L.; Weeks, K.M. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009, 460, 711-716. [CrossRef] [PubMed]
104. Yilmaz, A.; Bolinger, C.; Boris-Lawrie, K. Retrovirus translation initiation: Issues and hypotheses derived from study of HIV-1. Curr. HIV Res. 2006, 4, 131-139. [CrossRef] [PubMed]
105. Geballe, A.P.; Gray, M.K. Variable inhibition of cell-free translation by HIV-1 transcript leader sequences. Nucleic Acids Res. 1992, 20, 4291-4297. [CrossRef] [PubMed]
106. Parkin, N.T.; Cohen, E.A.; Darveau, A.; Rosen, C.; Haseltine, W.; Sonenberg, N. Mutational analysis of the 5ʹ non-coding region of human immunodeficiency virus type 1: Effects of secondary structure on translation. EMBO J. 1988, 7, 2831-2837. [PubMed]
107. SenGupta, D.N.; Berkhout, B.; Gatignol, A.; Zhou, A.M.; Silverman, R.H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1990, 87, 7492-7496. [CrossRef] [PubMed]
108. Svitkin, Y.V.; Pause, A.; Sonenberg, N. La autoantigen alleviates translational repression by the 5ʹ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 1994, 68, 7001-7007. [PubMed]
109. Soto-Rifo, R.; Limousin, T.; Rubilar, P.S.; Ricci, E.P.; Decimo, D.; Moncorge, O.; Trabaud, M.A.; André, P.; Cimarelli, A.; Ohlmann, T.; et al. Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation. Nucleic Acids Res. 2012, 40, 2653-2667. [CrossRef] [PubMed]
110. Dorin, D.; Bonnet, M.C.; Bannwarth, S.; Gatignol, A.; Meurs, E.F.; Vaquero, C. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J. Biol. Chem. 2003, 278, 4440-4448. [CrossRef] [PubMed]
111. Dugre-Brisson, S.; Elvira, G.; Boulay, K.; Chatel-Chaix, L.; Mouland, A.J.; DesGroseillers, L. Interaction of Staufen1 with the 5ʹ end of mRNA facilitates translation of these RNAs. Nucleic Acids Res. 2005, 33, 4797-4812. [CrossRef] [PubMed]
112. Miele, G.; Mouland, A.; Harrison, G.P.; Cohen, E.; Lever, A.M. The human immunodeficiency virus type 1 5ʹ packaging signal structure affects translation but does not function as an internal ribosome entry site structure. J. Virol. 1996, 70, 944-951. [PubMed]
113. Brasey, A.; Lopez-Lastra, M.; Ohlmann, T.; Beerens, N.; Berkhout, B.; Darlix, J.L.; Sonenberg, N. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J. Virol. 2003, 77, 3939-3949. [CrossRef] [PubMed]
114. Andersen, J.L.; Planelles, V. The role of Vpr in HIV-1 pathogenesis. Curr. HIV Res. 2005, 3, 43-51. [CrossRef] [PubMed]
115. Elder, R.T.; Benko, Z.; Zhao, Y. HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front. Biosci. 2002, 7, d349-d357. [CrossRef] [PubMed]
116. Gemeniano, M.C.; Sawai, E.T.; Sparger, E.E. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest. Virology 2004, 325, 167-174. [CrossRef] [PubMed]
117. He, J.; Choe, S.; Walker, R.; di Marzio, P.; Morgan, D.O.; Landau, N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995, 69, 6705-6711. [PubMed]
118. Fan, H.; Penman, S. Regulation of protein synthesis in mammalian cells. II. Inhibition of protein synthesis at the level of initiation during mitosis. J. Mol. Biol. 1970, 50, 655-670. [CrossRef]
119. Tarnowka, M.A.; Baglioni, C. Regulation of protein synthesis in mitotic HeLa cells. J. Cell. Physiol. 1979, 99, 359-367. [CrossRef] [PubMed]
120. Goh, W.C.; Rogel, M.E.; Kinsey, C.M.; Michael, S.F.; Fultz, P.N.; Nowak, M.A.; Hahn, B.H.; Emerman, M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 1998, 4, 65-71. [CrossRef] [PubMed]
121. Monette, A.; Valiente-Echeverria, F.; Rivero, M.; Cohen, E.A.; Lopez-Lastra, M.; Mouland, A.J. Dual mechanisms of translation initiation of the full-length HIV-1 mRNA contribute to gag synthesis. PLoS ONE 2013, 8, e68108. [CrossRef] [PubMed]
122. Sharma, A.; Yilmaz, A.; Marsh, K.; Cochrane, A.; Boris-Lawrie, K. Thriving under stress: Selective translation of HIV-1 structural protein mRNA during Vpr-mediated impairment of eif4e translation activity. PLoS Pathog. 2012, 8, e1002612. [CrossRef] [PubMed]
123. Amorim, R.; Costa, S.M.; Cavaleiro, N.P.; da Silva, E.E.; da Costa, L.J. HIV-1 transcripts use IRES-initiation under conditions where Cap-dependent translation is restricted by poliovirus 2A protease. PLoS ONE 2014, 9, e88619. [CrossRef] [PubMed]
124. Plank, T.D.; Whitehurst, J.T.; Kieft, J.S. Cell type specificity and structural determinants of IRES activity from the 5ʹ leaders of different HIV-1 transcripts. Nucleic Acids Res. 2013, 41, 6698-6714. [CrossRef] [PubMed]
125. Vallejos, M.; Deforges, J.; Plank, T.D.; Letelier, A.; Ramdohr, P.; Abraham, C.G.; Valiente-Echeverría, F.; Kieft, J.S.; Sargueil, B.; López-Lastra, M.; et al. Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors. Nucleic Acids Res. 2011, 39, 6186-6200. [CrossRef] [PubMed]
126. Vallejos, M.; Carvajal, F.; Pino, K.; Navarrete, C.; Ferres, M.; Huidobro-Toro, J.P.; Sargueil, B.; López-Lastra, M. Functional and structural analysis of the internal ribosome entry site present in the mRNA of natural variants of the HIV-1. PLoS ONE 2012, 7, e35031. [CrossRef] [PubMed]
127. Valiente-Echeverria, F.; Vallejos, M.; Monette, A.; Pino, K.; Letelier, A.; Huidobro-Toro, J.P.; Mouland, A.J.; López-Lastra, M. A cis-acting element present within the Gag open reading frame negatively impacts on the activity of the HIV-1 IRES. PLoS ONE 2013, 8, e56962. [CrossRef] [PubMed]
128. Gendron, K.; Ferbeyre, G.; Heveker, N.; Brakier-Gingras, L. The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory element. Nucleic Acids Res. 2011, 39, 902-912. [CrossRef] [PubMed]
129. Charnay, N.; Ivanyi-Nagy, R.; Soto-Rifo, R.; Ohlmann, T.; Lopez-Lastra, M.; Darlix, J.L. Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein. Retrovirology 2009, 6. [CrossRef] [PubMed]
130. Rivas-Aravena, A.; Ramdohr, P.; Vallejos, M.; Valiente-Echeverria, F.; Dormoy-Raclet, V.; Rodriguez, F.; Pino, K.; Holzmann, C.; Huidobro-Toro, J.P.; Gallouzi, I.E.; et al. The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites. Virology 2009, 392, 178-185. [CrossRef] [PubMed]
131. Alvarez, E.; Menendez-Arias, L.; Carrasco, L. The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J. Virol. 2003, 77, 12392-12400. [CrossRef] [PubMed]
132. Castello, A.; Franco, D.; Moral-Lopez, P.; Berlanga, J.J.; Alvarez, E.; Wimmer, E.; Carrasco, L. HIV-1 protease inhibits Cap-and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS ONE 2009, 4, e7997. [CrossRef] [PubMed]
133. Ohlmann, T.; Prevot, D.; Decimo, D.; Roux, F.; Garin, J.; Morley, S.J.; Darlix, J.L. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J. Mol. Biol. 2002, 318, 9-20. [CrossRef]
134. Ventoso, I.; Blanco, R.; Perales, C.; Carrasco, L. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc. Natl. Acad. Sci. USA 2001, 98, 12966-12971. [CrossRef] [PubMed]
135. Chamond, N.; Locker, N.; Sargueil, B. The different pathways of HIV genomic RNA translation. Biochem. Soc. Trans. 2010, 38, 1548-1552. [CrossRef] [PubMed]
136. Buck, C.B.; Shen, X.; Egan, M.A.; Pierson, T.C.; Walker, C.M.; Siliciano, R.F. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J. Virol. 2001, 75, 181-191. [CrossRef] [PubMed]
137. Camerini, V.; Decimo, D.; Balvay, L.; Pistello, M.; Bendinelli, M.; Darlix, J.L.; Ohlmann, T. A dormant internal ribosome entry site controls translation of feline immunodeficiency virus. J. Virol. 2008, 82, 3574-3583. [CrossRef] [PubMed]
138. Herbreteau, C.H.; Weill, L.; Decimo, D.; Prevot, D.; Darlix, J.L.; Sargueil, B.; Ohlmann, T. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat. Struct. Mol. Biol. 2005, 12, 1001-1007. [CrossRef] [PubMed]
139. Nicholson, M.G.; Rue, S.M.; Clements, J.E.; Barber, S.A. An internal ribosome entry site promotes translation of a novel SIV Pr55(Gag) isoform. Virology 2006, 349, 325-334. [CrossRef] [PubMed]
140. De Breyne, S.; Chamond, N.; Decimo, D.; Trabaud, M.A.; Andre, P.; Sargueil, B.; Ohlmann, T. In vitro studies reveal that different modes of initiation on HIV-1 mRNA have different levels of requirement for eukaryotic initiation factor 4F. FEBS J. 2012, 279, 3098-3111. [CrossRef] [PubMed]
141. Weill, L.; James, L.; Ulryck, N.; Chamond, N.; Herbreteau, C.H.; Ohlmann, T.; Sargueil, B. A new type of IRES within gag coding region recruits three initiation complexes on HIV-2 genomic RNA. Nucleic Acids Res. 2010, 38, 1367-1381. [CrossRef] [PubMed]
142. Locker, N.; Chamond, N.; Sargueil, B. A conserved structure within the HIV gag open reading frame that controls translation initiation directly recruits the 40S subunit and eIF3. Nucleic Acids Res. 2011, 39, 2367-2377. [CrossRef] [PubMed]
143. Ricci, E.P.; Herbreteau, C.H.; Decimo, D.; Schaupp, A.; Datta, S.A.; Rein, A.; Darlix, J.L.; Ohlmann, T. In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyprotein. RNA 2008, 14, 1443-1455. [CrossRef] [PubMed]
144. Berkhout, B.; Arts, K.; Abbink, T.E. Ribosomal scanning on the 5ʹ-untranslated region of the human immunodeficiency virus RNA genome. Nucleic Acids Res. 2011, 39, 5232-5244. [CrossRef] [PubMed]
145. Bolinger, C.; Sharma, A.; Singh, D.; Yu, L.; Boris-Lawrie, K. RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38, 1686-1696. [CrossRef] [PubMed]
146. Yedavalli, V.S.; Neuveut, C.; Chi, Y.H.; Kleiman, L.; Jeang, K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119, 381-392. [CrossRef] [PubMed]
147. Soto-Rifo, R.; Ohlmann, T. The role of the DEAD-box RNA helicase DDX3 in mRNA metabolism. Wiley Interdiscip. Rev. RNA 2013, 4, 369-385. [CrossRef] [PubMed]
148. Linder, P.; Jankowsky, E. From unwinding to clamping-The DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 2011, 12, 505-516. [CrossRef] [PubMed]
149. Soto-Rifo, R.; Rubilar, P.S.; Limousin, T.; de Breyne, S.; Decimo, D.; Ohlmann, T. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 2012, 31, 3745-3756. [CrossRef] [PubMed]
150. Soto-Rifo, R.; Rubilar, P.S.; Ohlmann, T. The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNA. Nucleic Acids Res. 2013, 41, 6286-6299. [CrossRef] [PubMed]
151. Lai, M.C.; Wang, S.W.; Cheng, L.; Tarn, W.Y.; Tsai, S.J.; Sun, H.S. Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation. PLoS ONE 2013, 8, e68665. [CrossRef] [PubMed]
152. Yedavalli, V.S.; Jeang, K.T. Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc. Natl. Acad. Sci. USA 2010, 107, 14787-14792. [CrossRef] [PubMed]
153. 2.2.7G differ in intrinsic translation efficiency. Nucleic Acids Res. 1988, 16, 8953-8962. [CrossRef] [PubMed]
154. Worch, R.; Niedzwiecka, A.; Stepinski, J.; Mazza, C.; Jankowska-Anyszka, M.; Darzynkiewicz, E.; Cusack, S.; Stolarski, R. Specificity of recognition of mRNA 5ʹ cap by human nuclear cap-binding complex. RNA 2005, 11, 1355-1363. [CrossRef] [PubMed]
155. Decker, C.J.; Parker, R. P-bodies and stress granules: Possible roles in the control of translation and mRNA degradation. Cold Spring Harb. Perspect. Biol. 2012, 4. [CrossRef] [PubMed]
156. Stoecklin, G.; Kedersha, N. Relationship of GW/P-bodies with stress granules. Adv. Exp. Med. Biol. 2013, 768, 197-211. [PubMed]
157. Lloyd, R.E. Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip. Rev. RNA 2013, 4, 317-331. [CrossRef] [PubMed]
158. Reineke, L.C.; Lloyd, R.E. Diversion of stress granules and P-bodies during viral infection. Virology 2013, 436, 255-267. [CrossRef] [PubMed]
159. Valiente-Echeverria, F.; Melnychuk, L.; Mouland, A.J. Viral modulation of stress granules. Virus Res. 2012, 169, 430-437. [CrossRef] [PubMed]
160. Nathans, R.; Chu, C.Y.; Serquina, A.K.; Lu, C.C.; Cao, H.; Rana, T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 2009, 34, 696-709. [CrossRef] [PubMed]
161. Chable-Bessia, C.; Meziane, O.; Latreille, D.; Triboulet, R.; Zamborlini, A.; Wagschal, A.; Jacquet, J.M.; Reynes, J.; Levy, Y.; Saib, A.; et al. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009, 6. [CrossRef] [PubMed]
162. Abrahamyan, L.G.; Chatel-Chaix, L.; Ajamian, L.; Milev, M.P.; Monette, A.; Clement, J.F.; Song, R.; Lehmann, M.; DesGroseillers, L.; Laughrea, M.; et al. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 2010, 123, 369-383. [CrossRef] [PubMed]
163. Phalora, P.K.; Sherer, N.M.; Wolinsky, S.M.; Swanson, C.M.; Malim, M.H. HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. J. Virol. 2012, 86, 11712-11724. [CrossRef] [PubMed]
164. Reed, J.C.; Molter, B.; Geary, C.D.; McNevin, J.; McElrath, J.; Giri, S.; Klein, K.C.; Lingappa, J.R. HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly. J. Cell Biol. 2012, 198, 439-456. [CrossRef] [PubMed]
165. Valiente-Echeverria, F.; Melnychuk, L.; Vyboh, K.; Ajamian, L.; Gallouzi, I.E.; Bernard, N.; Mouland, A.J. eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection. Nat. Commun. 2014, 5. [CrossRef] [PubMed]
166. Soto-Rifo, R.; Valiente-Echeverria, F.; Rubilar, P.S.; Garcia-de-Gracia, F.; Ricci, E.P.; Limousin, T.; Décimo, D.; Mouland, A.J.; Ohlmann, T. HIV-2 genomic RNA accumulates in stress granules in the absence of active translation. Nucleic Acids Res. 2014, 42, 12861-12875. [CrossRef] [PubMed]
167. Braddock, M.; Thorburn, A.M.; Chambers, A.; Elliott, G.D.; Anderson, G.J.; Kingsman, A.J.; Kingsman, S.M. A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell 1990, 62, 1123-1133. [CrossRef]
168. Braddock, M.; Powell, R.; Blanchard, A.D.; Kingsman, A.J.; Kingsman, S.M. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes. FASEB J. 1993, 7, 214-222. [PubMed]
169. SenGupta, D.N.; Silverman, R.H. Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res. 1989, 17, 969-978. [CrossRef] [PubMed]
170. Edery, I.; Petryshyn, R.; Sonenberg, N. Activation of double-stranded RNA-dependent kinase (DSL) by the TAR region of HIV-1 mRNA: A novel translational control mechanism. Cell 1989, 56, 303-312. [CrossRef]
171. Williams, B.R. Signal integration via PKR. Sci. STKE 2001, 2001. [CrossRef] [PubMed]
172. Clerzius, G.; Gelinas, J.F.; Gatignol, A. Multiple levels of PKR inhibition during HIV-1 replication. Rev. Med. Virol. 2011, 21, 42-53. [CrossRef] [PubMed]
173. Charbonneau, J.; Gendron, K.; Ferbeyre, G.; Brakier-Gingras, L. The 5ʹ UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed-1 ribosomal frameshift that generates HIV-1 enzymes. RNA 2012, 18, 519-529. [CrossRef] [PubMed]
174. Arrigo, S.J.; Chen, I.S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 1991, 5, 808-819. [CrossRef] [PubMed]
175. Kimura, T.; Hashimoto, I.; Nishikawa, M.; Fujisawa, J.I. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression. Biochimie 1996, 78, 1075-1080. [CrossRef]
176. Campbell, L.H.; Borg, K.T.; Haines, J.K.; Moon, R.T.; Schoenberg, D.R.; Arrigo, S.J. Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J. Virol. 1994, 68, 5433-5438. [PubMed]
177. Groom, H.C.; Anderson, E.C.; Dangerfield, J.A.; Lever, A.M. Rev regulates translation of human immunodeficiency virus type 1 RNAs. J. Gen. Virol. 2009, 90, 1141-1147. [CrossRef] [PubMed]
178. Anderson, E.C.; Lever, A.M. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J. Virol. 2006, 80, 10478-10486. [CrossRef] [PubMed]